| |
Thursday, April 3, 2025 | 11am ET / 8am PT Join us for an insightful webinar on the latest advancements in cell and gene therapy, focusing on the innovative Cas9-CLIPT (Cleaved, Linearized with Protein Template) technology. Learn more about this groundbreaking technology designed to improve the efficiency of genome editing. Register now.
|
|
| By Gabrielle Masson President Donald Trump’s Department of Government Efficiency has again revised savings estimates tied to federal site closures, nearly halving the unit’s initial forecast. The agency has also removed 91 federal sites previously listed on its “wall of receipts” for planned lease cancellations, including three FDA sites. |
|
|
|
By Gabrielle Masson The federal government is cutting 3,500 full-time FDA employees and 1,200 NIH workers as part of an overarching move designed to eliminate 10,000 jobs in the Department of Health and Human Services. |
By Angus Liu After threatening a month ago to impose “25% or higher” tariffs on foreign-made pharmaceuticals, President Donald Trump has doubled down on the pledge, although the exact timing and scope of their implementation remains unclear. |
By Gabrielle Masson As the U.S. cuts federal research funding and infrastructure, European countries are strategizing ways to attract top scientific talent, with the Netherlands government setting up a fund designed to do just that. |
|
Tuesday, April 8, 2025 | 1pm ET / 10am PT Learn how AI-powered digital phenotyping and real-world data (RWD) help identify overlooked patient populations, bridge gaps between clinical guidelines and real-world treatment, and refine commercial strategies. Join experts to discover how AI-driven insights can optimize market positioning and ensure therapies reach the right patients. Register now!
|
|
By Angus Liu Novo Nordisk has quickly expanded its discounted Wegovy program, now offering all eligible cash-paying customers its popular weight-loss med at $499 per month. |
By Andrea Park As the college basketball March Madness tournament gets underway, so too does Fierce Pharma Marketing’s annual #FierceMadness competition. |
By Conor Hale After outlining plans nearly one year ago to take 23andMe private—and submitting multiple offers—co-founder and CEO Anne Wojcicki will now resign as chief of the genetic testing company as it files for Chapter 11 bankruptcy and instead pursues a court-managed sale. |
By Fraiser Kansteiner Biogen on Monday said it signed a 15-year lease for a building at Cambridge’s Kendall Common that the company plans to use as its new global headquarters. The Big Biotech says it will move its current Cambridge-based employees to the site at the time of its expected opening in 2028, which will coincide with Biogen’s 50th anniversary. |
By Kevin Dunleavy Johnson & Johnson will invest $55 billion in the U.S. over the next four years. The announcement comes a month after Eli Lilly revealed a similar U.S.-focused plan to boost its manufacturing base. |
By Darren Incorvaia After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of a natural experiment to look for more definitive evidence that the shot can reduce dementia risk. |
By Nick Paul Taylor The PMCPA has dug into the industry’s LinkedIn activities once again. AstraZeneca received the harshest censure in the latest set of cases, taking a telling-off over one of its own posts, while Pfizer escaped with a slap on the wrist after its employees got too liberal with their LinkedIn likes. |
Fierce podcastsDon’t miss an episode |
| | Pair Team supports community-based organizations via California's Medi-Cal Community Care Hubs model. |
|
|---|
|
|
|
Wednesday, April 9, 2025 | 10am ET / 7am PT Learn the key steps for successfully entering Japan’s pharmaceutical market. This webinar covers regulatory requirements, compliance strategies, supply chain best practices, and common challenges. Gain expert insights to navigate this high-potential market with confidence. Don’t miss out—register now to secure your spot!
|
|
| WhitepaperRead about four trends that will shape the innovations, therapies, & market landscape in oncology during 2025 & beyond. Presented by Blue Matter, strategic consultants in the life sciences |
| WhitepaperDiscover how to revolutionize your vaccine trials with Avacare's latest white paper. Gain exclusive access to innovative, data-driven recruitment strategies that ensure diverse, efficient, and high-quality vaccine trials. Sponsored by: Avacare Clinical Research Network |
| WhitepaperDevelop your CAR molecule faster Sponsored by: Cell Signaling Technology |
| |
|
